|
English
|
正體中文
|
简体中文
|
總筆數 :2856565
|
|
造訪人次 :
53427976
線上人數 :
678
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 414846-414855 / 2348973 (共234898頁)
<< < 41480 41481 41482 41483 41484 41485 41486 41487 41488 41489 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-03-03T03:36:44Z |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
Huang S.-Y.; CHUNG-WU LIN; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
HWEI-FANG TIEN; Chou S.-J.; Chou W.-C.; Tsay W.; Chen C.-Y.; Hou H.-A.; Lu H.-Y.; Chen Y.-C.; Wu S.-J.; Tang J.-L.; Lin H.-H.; Yao M.; Huang S.-Y.; Lin C.-W. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
MING YAO; Lin C.-W.; Lin H.-H.; Huang S.-Y.; Chou S.-J.; Chou W.-C.; Tsay W.; Chen C.-Y.; Hou H.-A.; Chen Y.-C.; Lu H.-Y.; Wu S.-J.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:33Z |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
Huang S.-Y.; Lin C.-W.; Lin H.-H.; Yao M.; JIH-LUH TANG; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
SHANG-YI HUANG; Lin C.-W.; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.; Tien H.-F. |
| 國立臺灣大學 |
2004 |
Expression of Chemokine and Receptors in Lewis Rats with Experimental Autoimmune Anterior Uveitis
|
方怡謨; 楊長豪; 林昌平; 楊中美; 陳慕師; FAN, I-MORE; YANG, CHANG-HAO; LIN, CHANG-PING; YANG, CHUNG-MAY; CHEN, MUH-SHY |
| 臺大學術典藏 |
2018-09-10T04:43:04Z |
Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis
|
Fang, I.-M.;Yang, C.-H.;Lin, C.-P.;Yang, C.-M.;Chen, M.-S.; CHUNG-MAY YANG; CHANG-HAO YANG |
| 臺大學術典藏 |
2022-07-14T07:26:07Z |
Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis
|
Fang I.-M.; CHANG-HAO YANG; Lin C.-P.; Yang C.-M.; Chen M.-S. |
| 臺大學術典藏 |
2022-07-15T06:43:45Z |
Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis
|
Fang I.-M.; Yang C.-H.; Lin C.-P.; CHUNG-MAY YANG; Chen M.-S. |
| 中國醫藥大學 |
2004-04-28 |
Expression of Chemokine Receptor CXCR4 Enhances Tumorigenesis of Basal Cell Carcinoma
|
吳孟澤(Wu,Meng-Tse); 吳孟澤(Wu,Meng-Tse); 吳孟澤(Wu,Meng-Tse) |
顯示項目 414846-414855 / 2348973 (共234898頁)
<< < 41480 41481 41482 41483 41484 41485 41486 41487 41488 41489 > >>
每頁顯示[10|25|50]項目
|
